title: Tolcapone and fulminant hepatitis.
authors.forename: F
authors.initials: F
authors.lastname: Assal
authors.forename: L
authors.initials: L
authors.lastname: Spahr
authors.forename: A
authors.initials: A
authors.lastname: Hadengue
authors.forename: L
authors.initials: L
authors.lastname: Rubbia-Brandt
authors.forename: P R
authors.initials: PR
authors.lastname: Burkhard
authors.forename: L
authors.initials: L
authors.lastname: Rubbici-Brandt
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001577:Benzophenones / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006801:Humans; D017114:Liver Failure, Acute / Q000139:chemically induced; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy; D000077867:Tolcapone
chemical_list: D000978:Antiparkinson Agents; D001577:Benzophenones; D009596:Nitrophenols; D000077867:Tolcapone